Results 21 to 30 of about 87,360 (270)

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Cefiderocol - a promising new antibiotic for the antibiotic-resistant pathogens of the highest epidemiological priority

open access: yesJournal of Education, Health and Sport, 2019
Increase in the incidence of multidrug-resistant Gram-negative bacterial strains pose a significant threat to healthcare system worldwide. New antibiotics are necessary to combat particularly resitant pathogens.
Karol Lorenc Lorenc   +7 more
doaj   +3 more sources

Acute localized exanthematous pustulosis of the leg: A case report

open access: yesJEADV Clinical Practice, 2023
We report a case of an unusually located site of acute localized exanthematous pustulosis in the right lower limb of a patient treated with beta‐lactams which resolved upon cessation. This case report highlights the need for vigilance as well as an index
Wen Shuo Tiong   +2 more
doaj   +1 more source

Oral Cephalosporins [PDF]

open access: yesActa Clinica Belgica, 1992
The arrival of new cephalosporins faces the clinician with an evergrowing confusion as to the drug of choice. The older agents (cephalexin, cephradine, cefadroxil and cefaclor) and the newer formulations cefatrizine and cefuroxime axetil are intensively used for treatment of mild and moderate infections.
J, Verhaegen, L, Verbist
openaire   +4 more sources

Insights into the Versatility of Using Atomic Absorption Spectrometry in Antibacterial Research

open access: yesMolecules
The ongoing development of bacterial resistance to antibiotics is a global challenge. Research in that field is thus necessary. Analytical techniques are required for such a purpose. From this perspective, the focus was on atomic absorption spectrometry (
David Krüger   +3 more
doaj   +1 more source

Detection of Cephalosporin and Fluoroquinolone Resistance Genes via Novel Multiplex qPCR in Fecal Salmonella Isolates From Northern Californian Dairy Cattle, 2002–2016

open access: yesFrontiers in Microbiology, 2021
The objectives of this study were to evaluate the prevalence of extended spectrum β-lactamase (ESBL) genes, AmpC-type β-lactamase (ACBL) genes, and plasmid mediated quinolone resistance (PMQR) genes in Salmonella isolated at a Veterinary Medical Teaching
Carl Basbas   +6 more
doaj   +1 more source

Potential Factors of Primary Hospital Healthcare Professionals in Hindering the Abolition of Routine Skin Test for Cephalosporin: A Cross-Sectional Study

open access: yesRisk Management and Healthcare Policy, 2023
Bo Li,1,2 Li Jiang,1,2 Ni Wu,1,2 Yao Chen,1,2 Zhi Xu,3 Fengcheng Xu,2,4 Heping Chen,1 Tianhu Liu2,4 1Clinical Pharmacy Department, The Third Affiliated Hospital of Chengdu Medical College, Pidu District People’s Hospital, Chengdu, Sichuan, People’s ...
Li B   +7 more
doaj  

Management of Beta-Lactam Antibiotics Allergy: A Real-Life Study

open access: yesFrontiers in Allergy, 2022
Beta-lactam allergy is a common problem in everyday medical practice and is recognized as a major public health issue. Carrying this label frequently leads to the avoidance of all beta-lactam antibiotics, favoring the use of other less preferred classes ...
Sarah Iuliano   +13 more
doaj   +1 more source

Cephalosporin Antibiotics

open access: yesEar, Nose & Throat Journal, 1994
The last three decades have seen the emergence of a cornucopia of antimicrobials in the cephalosporin class. This becomes even more apparent when one realizes that over 60 pages of the 1993 AHFS drug information text is dedicated to the cephalosporin class.
R A, Otto, A D, Noorily
openaire   +2 more sources

Cephalosporin allergy label is misleading [PDF]

open access: yes, 2018
Penicillins and cephalosporins can cause a similar spectrum of allergic reactions at a similar rate. Cross-reactive allergy between penicillins and cephalosporins is rare, as is cross-reaction within the cephalosporin group. Patients should therefore not
Smith, William B.   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy